Tramadol Hydrochloride and Acetaminophen
Tramadol Hydrochloride and Acetaminophen is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Tramadol Hydrochloride and Acetaminophen; Generic name: TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN; Manufacturer: Medsource Pharmaceuticals.
| Brand name | Tramadol Hydrochloride and Acetaminophen |
|---|---|
| Generic name | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN |
| Manufacturer | Medsource Pharmaceuticals |
| Used for | 1 INDICATIONS AND USAGE Tramadol hydrochloride and acetaminophen tablets are indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use: Tramadol hydrochlorideandacetaminophen tablets are indicated for short-term use of five days or less. Because of the risks of addiction, abuse, and misuse with opioids, which can occur at any dosage or duration [see Warnings and Precautions (5.1) ] , reserve tramadol hydrochloride and acetaminophen tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics): Have not been tolerated orare not expected to be tolerated, Have |
| Dosage | 2 DOSAGE AND ADMINISTRATION Discuss availability of naloxone with the patient and caregiver and assess each patient’s need for access to naloxone, both when initiating and renewing treatment with tramadol hydrochloride and acetaminophen. Consider prescribing naloxone based on the patient’s risk factors for overdose ( 2.2 , 5.1 , 5.2 , 5.3 ). Do not use with other acetaminophen- or tramadol-containing products. ( 2 , 5.20 ) Tramadol hydrochloride and acetaminophen tablets should be prescribed onl |
| Warnings | WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF TRAMADOL HYDROCHLORIDE and ACETAMINOPHEN Addiction, Abuse, and Misuse Because the use of tramadol hydrochloride and acetaminophen exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death, assess each patient’s risk prior to prescribing and reassess all patients regularly for the development of these behaviors and conditions [see Warnings and Precautions (5.1) ]. Life-Threaten |
| Active ingredient(s) | ACETAMINOPHEN |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=12f113b3-d6b1-a7b0-e063-6294a90a999d |